What Omicron is teaching us; Teva held liable in opioid crisis

STAT looks beyond climbing case counts to outline what Omicron is already teaching us as this phase of the pandemic plays out. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

This newsletter will return in your inbox on Monday. Beyond case counts: What Omicron is teaching us By Andrew Joseph and Helen Branswell Amy Beth Bennett/South Florida Sun-Sentinel via AP With cases of the Covid-19 variant expected to surge over coming weeks, here's what we've learned so far about this phase of the pandemic. Read More New York jury holds Teva Pharmaceuticals liable in opioid crisis By Associated Press Dan Balilty/AP A jury held Teva responsible for contributing to the opioid crisis, delivering a verdict in a sweeping lawsuit filed by New York state. Read More Opinion: STAT+: Building a better on-ramp for health innovation By Laurent Levy Alex Hogan/STAT, ADOBE The process exists to help more great innovations reach their potential. Now it's time to build the system to support it. Read More Sponsor content by STAT+ Biopharma breakthroughs, business, and policy analysis ⁠— at your fingertips Enjoy daily, market-moving analysis of the biotech, pharma, and life sciences industries with STAT Plus. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Don't be the last to know. Subscribe today to start reading. We wish we'd written that: STAT staffers share their favorite stories of 2021 By STAT Staff Michael Ciaglo/Getty Images All through 2021, journalists around the globe writing on Covid-19 and other pressing issues have captivated and inspired our staff at STAT. Read More Thursday, December 30, 2021       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2021, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser